GB0706188D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0706188D0
GB0706188D0 GBGB0706188.0A GB0706188A GB0706188D0 GB 0706188 D0 GB0706188 D0 GB 0706188D0 GB 0706188 A GB0706188 A GB 0706188A GB 0706188 D0 GB0706188 D0 GB 0706188D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0706188.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0706188.0A priority Critical patent/GB0706188D0/en
Publication of GB0706188D0 publication Critical patent/GB0706188D0/en
Priority to PCT/EP2008/053595 priority patent/WO2008119716A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
GBGB0706188.0A 2007-03-29 2007-03-29 Compounds Ceased GB0706188D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0706188.0A GB0706188D0 (en) 2007-03-29 2007-03-29 Compounds
PCT/EP2008/053595 WO2008119716A1 (en) 2007-03-29 2008-03-27 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0706188.0A GB0706188D0 (en) 2007-03-29 2007-03-29 Compounds

Publications (1)

Publication Number Publication Date
GB0706188D0 true GB0706188D0 (en) 2007-05-09

Family

ID=38050504

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0706188.0A Ceased GB0706188D0 (en) 2007-03-29 2007-03-29 Compounds

Country Status (2)

Country Link
GB (1) GB0706188D0 (en)
WO (1) WO2008119716A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288412B2 (en) 2005-09-30 2012-10-16 Glaxo Group Limited Compounds which have activity at M1 receptor and their uses in medicine
DE602006019119D1 (en) 2005-09-30 2011-02-03 Glaxo Group Ltd COMPOUNDS WITH ACTIVITY AT THE M1 RECEPTOR AND THEIR USE IN MEDICINE
EP1937670A1 (en) 2005-09-30 2008-07-02 Glaxo Group Limited Benzimidazolones which have activity at m1 receptor
GB0718415D0 (en) 2007-09-20 2007-10-31 Glaxo Group Ltd Compounds
GB0912385D0 (en) 2009-07-16 2009-08-26 Syngenta Ltd Novel herbicides
PT3102568T (en) * 2014-02-06 2018-10-24 Heptares Therapeutics Ltd Bicyclic aza compounds as muscarinic m1 receptor agonists.
CN115745765A (en) * 2022-11-22 2023-03-07 浙大宁波理工学院 Preparation method of p-bromoalkylcyclohexanone compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329353A (en) * 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US5718912A (en) * 1996-10-28 1998-02-17 Merck & Co., Inc. Muscarine agonists
DE60235274D1 (en) * 2001-04-18 2010-03-18 Euro Celtique Sa Octahydrobenzimidazolone compounds as analgesics
WO2003105781A2 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension

Also Published As

Publication number Publication date
WO2008119716A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0700112D0 (en) Compounds
GB0700287D0 (en) Compounds
GB0705800D0 (en) Compounds
GB0702960D0 (en) Compounds
GB0701986D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)